Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: CE Approval For Xvivo's Perfusion Solution For Heart Preservation Is Delayed

July 29 (Reuters) - Xvivo Perfusion AB XVIVO.ST:

SAID ON MONDAY XVIVO HEART ASSIST TRANSPORT AND XVIVO HEART ASSIST TRANSPORT PERFUSION SET HAVE RECEIVED CE APPROVAL

ESTIMATES DELAYS OF 6-12 MONTHS FOR CE APPROVAL OF XVIVO'S HEART PERFUSION SOLUTION AND SUPPLEMENT DUE TO CONSULTATION PROCESS AT EU COMPETENT AUTHORITY

 Source text for Workspace: nMFNc7yfBS
 Further company coverage: XVIVO.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Xvivo Perfusion AB

See all news